<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T04:45:35Z</responseDate>
  <request identifier="oai:figshare.com:article/33917078" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33917078</identifier>
        <datestamp>2026-09-18T02:03:48Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Enantioselective
Synthesis of Spiropyrrolidines by
Synergistic Catalysis</dc:title>
          <dc:creator>Michael Franc (19965025)</dc:creator>
          <dc:creator>Ivana Císařová (1580947)</dc:creator>
          <dc:creator>Jan Veselý (1843195)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>good combined yields</dc:subject>
          <dc:subject>enantioselectivities reaching 99</dc:subject>
          <dc:subject>optimized reaction conditions</dc:subject>
          <dc:subject>achiral palladium catalysis</dc:subject>
          <dc:subject>reaction partners</dc:subject>
          <dc:subject>work highlights</dc:subject>
          <dc:subject>synergistic catalysis</dc:subject>
          <dc:subject>stereoselective methodology</dc:subject>
          <dc:subject>metal catalysis</dc:subject>
          <dc:subject>high diastereoselectivities</dc:subject>
          <dc:subject>enantiomeric purity</dc:subject>
          <dc:subject>efficient construction</dc:subject>
          <dc:subject>broad range</dc:subject>
          <dc:subject>aldimines derived</dc:subject>
          <dc:subject>activated vinylcyclopropanes</dc:subject>
          <dc:subject>83 %),</dc:subject>
          <dc:subject>12 dr</dc:subject>
          <dc:description>A stereoselective methodology for the synthesis of highly
substituted
spiropyrrolidines via synergistic catalysis was developed. The transformation
is based on a cooperative catalytic system combining chiral phosphoric
acid (CPA) catalysis with achiral palladium catalysis and proceeds
through a formal [3+2] cycloaddition of activated vinylcyclopropanes
with aldimines derived from imidazolones. Under the optimized reaction
conditions, a broad range of spiropyrrolidines were obtained in good
combined yields (up to 83%), with high diastereoselectivities (up
to 1:12 dr) and enantioselectivities reaching 99% ee. The developed
methodology tolerates various substitutions on both of the reaction
partners. Furthermore, selected synthetic transformations demonstrated
the utility of the obtained spiropyrrolidines for further derivatization
while retaining the enantiomeric purity. This work highlights the
potential of synergistic CPA/transition-metal catalysis for the efficient
construction of structurally complex chiral spiropyrrolidine scaffolds.</dc:description>
          <dc:date>2026-09-17T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.joc.6c01686.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Enantioselective_Synthesis_of_Spiropyrrolidines_by_Synergistic_Catalysis/33917078</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
